{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:27:21Z","timestamp":1791502041743,"version":"4.3.4"},"reference-count":31,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Parkinson\u2019s Disease"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In anticipation of future clinical trials involving individuals with Parkinson's disease (PD), it is important to have fully validated, clinically-relevant, responsive, disease-specific patient-reported outcome measures that are capable of serially measuring how an individual with PD feels and functions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To develop and validate a disease-specific patient-reported outcome measure for PD that is sensitive in detecting clinically meaningful changes in multifactorial disease burden during clinical trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted qualitative interviews and a cross-sectional study to identify the most important symptoms to individuals with PD. Symptom questions with the highest frequency and relative importance to the cross-sectional study cohort were selected for potential inclusion in the Parkinson's Disease-Health Index (PD-HI). The PD-HI was evaluated and refined through: 1) Qualitative beta interviews; 2) Test-retest reliability assessments; 3) Internal consistency analysis; and 4) Cross-sectional subgroup analysis of PD-HI subscale scores.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty individuals with PD participated in initial qualitative interviews and 404 individuals with PD participated in the cross-sectional study. Symptom questions representing 13 symptomatic themes of PD health were selected for inclusion in the PD-HI. Beta interview participants found the PD-HI to be comprehensive, relevant, and easy to use. The PD-HI demonstrated high test-retest reliability (ICC = 0.90) and internal consistency (\u03b1= 0.99). PD-HI total and subscale scores successfully distinguished between subgroups of participants with varying disease severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Initial evaluation of the PD-HI demonstrates its content validity, construct validity, usability, and test-retest reliability as a patient-reported outcome tool for potential use in PD clinical trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/1877718x261422098","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T13:20:20Z","timestamp":1773926420000},"page":"504-517","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["The Parkinson's Disease-Health Index: A novel, disease-specific patient-reported outcome measure"],"prefix":"10.1177","volume":"16","author":[{"given":"Jamison","family":"Seabury","sequence":"first","affiliation":[{"name":"University of Rochester, Center for Health + Technology, Rochester, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Weinstein","sequence":"additional","affiliation":[{"name":"University of Rochester, Center for Health + Technology, Rochester, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer","family":"Rosero","sequence":"additional","affiliation":[{"name":"University of Rochester, Center for Health + Technology, Rochester, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anika","family":"Varma","sequence":"additional","affiliation":[{"name":"University of Rochester, Center for Health + Technology, Rochester, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2982-8197","authenticated-orcid":false,"given":"Charlotte","family":"Engebrecht","sequence":"additional","affiliation":[{"name":"University of Rochester, Center for Health + Technology, Rochester, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7755-3336","authenticated-orcid":false,"given":"John","family":"Heatwole","sequence":"additional","affiliation":[{"name":"Cornell University, The College of Agriculture and Life Sciences, Ithaca, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Zizzi","sequence":"additional","affiliation":[{"name":"University of Rochester, Center for Health + Technology, Rochester, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5800-9022","authenticated-orcid":false,"given":"Nuran","family":"Dilek","sequence":"additional","affiliation":[{"name":"University of Rochester, Department of Biostatistics and Neurology, Rochester, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Arky","sequence":"additional","affiliation":[{"name":"Des Moines University College of Osteopathic Medicine, Des Moines, IA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Ray Dorsey","sequence":"additional","affiliation":[{"name":"University of Rochester, Center for Health + Technology, Rochester, NY, USA"},{"name":"University of Rochester, Department of Neurology, Rochester NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2900-6612","authenticated-orcid":false,"given":"Chad","family":"Heatwole","sequence":"additional","affiliation":[{"name":"University of Rochester, Center for Health + Technology, Rochester, NY, USA"},{"name":"University of Rochester, Department of Neurology, Rochester NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61393-3"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2015.09.004"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-009-5240-1"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(06)70373-8"},{"key":"e_1_3_3_6_2","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration. Guidance for industry: patient-reported outcome measures: use in medical product development to support drug labelling claims. Report U.S. Department of Health and Human Services USA 2009."},{"key":"e_1_3_3_7_2","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration. Principles for selecting developing modifying and adapting patient-reported outcome instruments for use in medical device evaluation: guidance for industry and Food and Drug Administration staff and other stakeholders. Report U.S. Department of Health and Human Services USA 2022."},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/bjaed\/mkw060"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21198"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02260863"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-017-0021-5"},{"key":"e_1_3_3_12_2","first-page":"45","article-title":"Fatigue evaluated using the 16-item Parkinson fatigue scale (PFS-16) predicts Parkinson's disease prognosis","volume":"5","author":"Niimi Y","year":"2019","unstructured":"Niimi Y, Shima S, Mizutani Y, et al. Fatigue evaluated using the 16-item Parkinson fatigue scale (PFS-16) predicts Parkinson's disease prognosis. Fujita Med J 2019; 5: 45\u201348.","journal-title":"Fujita Med J"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.73.6.629"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21152"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1353-8020(99)00062-0"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-022-00375-3"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1186\/s41687-022-00427-0"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23462"},{"key":"e_1_3_3_19_2","article-title":"What matters most to individuals with Parkinson\u2019s disease: results from qualitative interviews [abstract]","volume":"35","author":"Arky A","year":"2020","unstructured":"Arky A, Zizzi C, Dorsey ER, et al. What matters most to individuals with Parkinson\u2019s disease: results from qualitative interviews [abstract]. Mov Disord 2020; 35. Available from: https:\/\/www.mdsabstracts.org\/abstract\/what-matters-most-to-individuals-with-parkinsons-disease-results-from-qualitative-interviews\/.","journal-title":"Mov Disord"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27223"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.3233\/JHD-210506"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000200180"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000200300"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2023.2204871"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.24097"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25282"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2011.195"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.10011"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2004.05.007"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.24725"},{"key":"e_1_3_3_31_2","unstructured":"The Michael J. Fox Foundation for Parkinson's Research. Longitudinal endpoint optimization to provide an assessment of relevant drugs in Parkinson\u2019s disease (LEOPARD-PD). Available from: https:\/\/www.michaeljfox.org\/grant\/longitudinal-endpoint-optimization-provide-assessment-relevant-drugs-parkinsons-disease (accessed 19 July 2024)."},{"key":"e_1_3_3_32_2","unstructured":"National Institutes of Health National Library of Medicine. DB RCT for specialized phototherapy in Parkinson's disease (LIGHT-PD). Available from: https:\/\/clinicaltrials.gov\/study\/NCT04453033?term=PD-HI&rank=2 (accessed 19 July 2024)."}],"container-title":["Journal of Parkinson\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X261422098","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1877718X261422098","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X261422098","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:17:44Z","timestamp":1778840264000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1877718X261422098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1177\/1877718X261422098"],"URL":"https:\/\/doi.org\/10.1177\/1877718x261422098","relation":{},"ISSN":["1877-7171","1877-718X"],"issn-type":[{"value":"1877-7171","type":"print"},{"value":"1877-718X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]}}}